BenevolentAI
in house pipeline the business model leveraging our technology platform to generate new drug at scale decision criteria develop in house out license at end phase i or end phase milestones royalties collaborations selective platform collaborations which can leverage the platform in areas outside our core competencies economic bene platform validation data generated enriches the benevolent non commercial collaborations covid platform validation data generated enriches the benevolent | BenevolentAI
Company
Deck Type
Sector
Industry
Deck date
October 2022
Slide
12 of 46
Similar slides by BenevolentAI
See diffirences between slides (animation)
Results
March 2023
our business model unlocks multiple routes to value creation discovery tools owned pipeline platform generated assets in house development licensing platform generated assets out licensed at end phase i or end platform collaborations economic bene platform validation data generated enriches the benevolent non commercial collaborations platform validation data generated enriches the benevolent flexible | BenevolentAI
Investor Conference
January 2023
our business model unlocks multiple routes to value creation flexible | BenevolentAI
Investor Conference
November 2022
in house pipeline the business model leveraging our technology platform to generate new drug at scale decision criteria develop in house out license at end phase i or end phase milestones royalties collaborations selective platform collaborations which can leverage the platform in areas outside our core competencies economic bene platform validation data generated enriches the benevolent non commercial collaborations covid platform validation data generated enriches the benevolent | BenevolentAI
Investor Day
September 2022
in house pipeline the business model leveraging our technology platform to generate new drug at scale decision criteria develop in house out license at end phase i or end phase milestones royalties collaborations selective platform collaborations which can leverage the platform in areas outside our core competencies economic bene platform validation data generated enriches the benevolent non commercial collaborations covid platform validation data generated enriches the benevolent | BenevolentAI
Related slides by other companies
Near
SPAC
May 2022
what is near the near platform stitches and enriches data on people and places from which its customers can derive actionable intelligence to help them succeed | Near
Voyager Digital
Investor Presentation
March 2021
state of the art infrastructure behind the scenes | Voyager Digital
Allscripts Healthcare Solutions
Investor Day
September 2022
| Allscripts Healthcare Solutions
Vivid Seats
SPAC
April 2021
data platform and proprietary algorithms create unique value raw data platform algorithms benefits buyers sellers lechs | Vivid Seats
Other recent decks by BenevolentAI
See all presentations (10 decks)
Results
March 2024
Investor Conference
January 2024
Investor Presentation
May 2023
Results
March 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io